A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, January 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 93 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,220 followers.

A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study. https://t.co/ZsYi3BiyHd

30 Jul 2019

Reply Repost Favourite

Effect of LABA/LAMA on sleep in COPD https://t.co/OtvXGSz60a Mod-sev COPD : FEV1 46% ,SaO2 89% (Pts with sleep apnoea excl ) 4wk rand xover : N=22 IND/GLY vs n= 16 PL Primary EP : Mean Nightime SpO2 – NS diff Secondary EP’s : Nighttime spe…ht

11 Jan 2019

Reply Repost Favourite

Dove Medical Press

Article Metrics

A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

Mentioned by

Citations

Readers on